Investment Monitor on MSN
Samsung Biologics acquires GSK’s facility in Maryland, US
The US facility boosts local biomanufacturing, preserves jobs, and signals further growth in Maryland’s life sciences sector.
Pharma giant GSK (NYSE:GSK) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Pharma giant GSK (NYSE:GSK) ...
GSK (LSE:GSK) has received FDA approval for Lynavoy (linerixibat), the first treatment in the US for cholestatic pruritus in ...
GSK (LSE:GSK) secured Chinese approval for Exdensur for severe asthma patients aged 12 and older. The company also had its ...
GlaxoSmithKline ( (GB:GSK) ) just unveiled an announcement.
GSK (GSK) stock is in focus as the company wins FDA nod for Lynavoy, the first U.S. treatment for cholestatic pruritus in ...
GSK is sourcing early-stage science across a wide range of technologies and disease areas, while placing more selective bets ...
Technical indicators for Pfizer and GSK have turned bullish.
GSK has allied with SPH Kyuan Trade, a pharmaceutical import and distribution firm under Shanghai Pharma, to leverage its ...
GlaxoSmithKline Pakistan Limited reports a 53% rise in profit to Rs. 10 billion in 2025, driven by higher margins and strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results